Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Diseases

  Free Subscription


12.03.2018

1 Anticancer Res
7 Biochem Biophys Res Commun
4 BMC Cancer
1 Cancer
1 Cancer Res
6 Clin Res Hepatol Gastroenterol
1 Dig Dis
2 Dig Dis Sci
1 Gastroenterology
2 Gut
3 Hepatology
1 J Clin Oncol
8 J Hepatol
1 J Pediatr
1 Lancet
1 Lancet Gastroenterol Hepatol
1 Oncogene
4 PLoS One
5 Transplant Proc
2 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. TOYA R, Saito T, Shiraishi S, Kai Y, et al
    Dose-function Histogram Evaluation Using (99m)Tc-GSA SPECT/CT Images for Stereotactic Body Radiation Therapy Planning for Hepatocellular Carcinoma Patients: A Dosimetric Parameter Comparison.
    Anticancer Res. 2018;38:1511-1516.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. TAK H, Kang H, Ji E, Hong Y, et al
    Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2018 Feb 26. pii: S0006-291X(18)30435.
    PubMed     Text format     Abstract available

  3. DONG R, Guo J, Zhang Z, Zhou Y, et al
    Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts.
    Biochem Biophys Res Commun. 2018 Feb 28. pii: S0006-291X(18)30439.
    PubMed     Text format     Abstract available

  4. LIU D, Liu M, Wang W, Pang L, et al
    Overexpression of apoptosis-inducing factor mitochondrion-associated 1 (AIFM1) induces apoptosis by promoting the transcription of caspase3 and DRAM in hepatoma cells.
    Biochem Biophys Res Commun. 2018 Feb 28. pii: S0006-291X(18)30459.
    PubMed     Text format     Abstract available

  5. LIANG H, Wang Y
    Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C delta pathway.
    Biochem Biophys Res Commun. 2018 Mar 2. pii: S0006-291X(18)30470.
    PubMed     Text format     Abstract available

  6. LI YL, Zhang NY, Hu X, Chen JL, et al
    Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1alpha under hypoxia.
    Biochem Biophys Res Commun. 2018 Mar 2. pii: S0006-291X(18)30471.
    PubMed     Text format     Abstract available

  7. ZHU Q, Luo Z, Lu G, Gui F, et al
    LncRNA FABP5P3/miR-589-5p/ZMYND19 axis contributes to hepatocellular carcinoma cell proliferation, migration and invasion.
    Biochem Biophys Res Commun. 2018 Mar 6. pii: S0006-291X(18)30491.
    PubMed     Text format     Abstract available

  8. SHINAGAWA-KOBAYASHI Y, Kamimura K, Goto R, Ogawa K, et al
    Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model.
    Biochem Biophys Res Commun. 2018;496:556-561.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. YE SL, Yang J, Bie P, Zhang S, et al
    Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study.
    BMC Cancer. 2018;18:247.
    PubMed     Text format     Abstract available

  10. LEE DW, Lee KH, Kim HJ, Kim TY, et al
    A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma.
    BMC Cancer. 2018;18:252.
    PubMed     Text format     Abstract available

  11. RAMADORI G, Bosio P, Moriconi F, Malik IA, et al
    Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.
    BMC Cancer. 2018;18:257.
    PubMed     Text format     Abstract available

  12. BOCUK D, Wolff A, Krause P, Salinas G, et al
    The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model.
    BMC Cancer. 2017;17:342.
    PubMed     Text format     Abstract available


    Cancer

  13. ZHAI XF, Liu XL, Shen F, Fan J, et al
    Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study.
    Cancer. 2018 Mar 2. doi: 10.1002/cncr.30915.
    PubMed     Text format     Abstract available


    Cancer Res

  14. XU J, Yang Y, Xie R, Liu J, et al
    The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human hepatocellular carcinoma cells.
    Cancer Res. 2018 Mar 2. pii: 0008-5472.CAN-17-2061.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  15. WATSON A, Bul V, Staudacher J, Carroll R, et al
    The predictors of mortality and secular changes in management strategies in emphysematous gastritis.
    Clin Res Hepatol Gastroenterol. 2017;41:e1-e7.
    PubMed     Text format     Abstract available

  16. TAS A, Kara B, Yilmaz C, Suat Yalcin M, et al
    Fulminant Budd-Chiari syndrome due to ecstasy.
    Clin Res Hepatol Gastroenterol. 2017;41:e12-e13.
    PubMed     Text format    

  17. MOTAMED N, Rabiee B, Poustchi H, Dehestani B, et al
    Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Clin Res Hepatol Gastroenterol. 2017;41:31-38.
    PubMed     Text format     Abstract available

  18. SHIN JH, Jung JH
    Non-alcoholic fatty liver disease and flavonoids: Current perspectives.
    Clin Res Hepatol Gastroenterol. 2017;41:17-24.
    PubMed     Text format     Abstract available

  19. MANENTI A, Roncati L, Simonini E, Farinetti A, et al
    HCC chemoembolization: Still a challenge.
    Clin Res Hepatol Gastroenterol. 2017;41:e14-e16.
    PubMed     Text format    

  20. CHEN P, Yuan P, Chen B, Sun J, et al
    Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017;41:75-85.
    PubMed     Text format     Abstract available


    Dig Dis

  21. ZOU H, Yang X, Li QL, Zhou QX, et al
    A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients.
    Dig Dis. 2018 Mar 1. pii: 000486590. doi: 10.1159/000486590.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  22. DANIELSEN KV, Wiese S, Hove J, Bendtsen F, et al
    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-5006.
    PubMed     Text format     Abstract available

  23. ZOU WY, El-Serag HB, Sada YH, Temple SL, et al
    Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Dig Dis Sci. 2018 Mar 5. pii: 10.1007/s10620-018-4989.
    PubMed     Text format     Abstract available


    Gastroenterology

  24. HARVEY LD, Chan SY
    YAPping About Glutaminolysis in Hepatic Fibrosis.
    Gastroenterology. 2018 Mar 3. pii: S0016-5085(18)30259.
    PubMed     Text format    


    Gut


  25. Correction: Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis.
    Gut. 2018;67:782.
    PubMed     Text format    

  26. SINGH A, Smith PJ, Cropley IM, Planche KL, et al
    Gallstone mimicry: a rare cause of abdominal pain.
    Gut. 2016 Sep 29. pii: gutjnl-2016-312706. doi: 10.1136/gutjnl-2016-312706.
    PubMed     Text format    


    Hepatology

  27. ZHANG XP, Wang K, Guo WX, Chen ZH, et al
    Is sorafenib an optimal treatment for hepatocellular carcinoma with macrovascular invasion or metastatic disease?
    Hepatology. 2018 Mar 3. doi: 10.1002/hep.29862.
    PubMed     Text format    

  28. PHILIPS CA, Augustine P, Mathew S, Valiathan GC, et al
    Letter to the editor: Growth factor therapy for decompensated cirrhosis - Much ado about nothing?
    Hepatology. 2018 Mar 3. doi: 10.1002/hep.29866.
    PubMed     Text format    

  29. WU Y, Shan B, Dai J, Xia Z, et al
    Dual Role for Inositol-requiring Enzyme 1alpha in Promoting the Development of Hepatocellular Carcinoma during Diet-induced Obesity.
    Hepatology. 2018 Mar 5. doi: 10.1002/hep.29871.
    PubMed     Text format     Abstract available


    J Clin Oncol

  30. CHOW PKH, Gandhi M, Tan SB, Khin MW, et al
    SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.
    J Clin Oncol. 2018 Mar 2:JCO2017760892. doi: 10.1200/JCO.2017.76.0892.
    PubMed     Text format     Abstract available


    J Hepatol

  31. KARLSEN TH, Tacke F
    <<The times they are a'changin'>> - Positioning the European Association for the Study of the Liver in the changing landscape of hepatology.
    J Hepatol. 2018 Mar 1. pii: S0168-8278(18)30112.
    PubMed     Text format    

  32. NAULT JC, Galle PR, Marquardt JU
    The role of molecular enrichment on future therapies in hepatocellular carcinoma.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30134.
    PubMed     Text format     Abstract available

  33. LIU JJ, Li Y, Chen WS, Liang Y, et al
    Shp2 Deletion in Hepatocytes Suppresses Hepatocarcinogenesis Driven by Oncogenic beta-Catenin, PIK3CA and MET.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30131.
    PubMed     Text format     Abstract available

  34. WOOLBRIGHT BL, Jaeschke H
    Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure.
    J Hepatol. 2017;66:836-848.
    PubMed     Text format     Abstract available

  35. FERRERE G, Wrzosek L, Cailleux F, Turpin W, et al
    Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    J Hepatol. 2017;66:806-815.
    PubMed     Text format     Abstract available

  36. CARUSO S, Calderaro J, Letouze E, Nault JC, et al
    Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    J Hepatol. 2017;66:734-742.
    PubMed     Text format     Abstract available

  37. CHALAYE J, Costentin CE, Luciani A, Amaddeo G, et al
    Positron emission tomography / computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
    J Hepatol. 2018 Mar 5. pii: S0168-8278(18)30136.
    PubMed     Text format     Abstract available

  38. KOPEC AK, Joshi N, Cline-Fedewa H, Wojcicki AV, et al
    Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte alphaMbeta2 integrin-dependent upregulation of Mmp12.
    J Hepatol. 2017;66:787-797.
    PubMed     Text format     Abstract available


    J Pediatr

  39. LEE WS, Wong SY, Ivy DD, Sokol RJ, et al
    Hepatopulmonary Syndrome and Portopulmonary Hypertension in Children: Recent Advances in Diagnosis and Management.
    J Pediatr. 2018 Mar 5. pii: S0022-3476(17)31763.
    PubMed     Text format    


    Lancet

  40. HARRISON SA, Rinella ME, Abdelmalek MF, Trotter JF, et al
    NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2018 Mar 5. pii: S0140-6736(18)30474.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  41. VIOLI NV, Duran R, Guiu B, Cercueil JP, et al
    Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
    Lancet Gastroenterol Hepatol. 2018 Mar 1. pii: S2468-1253(18)30029.
    PubMed     Text format     Abstract available


    Oncogene

  42. DONG L, Yu L, Bai C, Liu L, et al
    USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis.
    Oncogene. 2018 Mar 2. pii: 10.1038/s41388-018-0137.
    PubMed     Text format     Abstract available


    PLoS One

  43. BENMASSAOUD A, Ghali P, Cox J, Wong P, et al
    Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.
    PLoS One. 2018;13:e0191985.
    PubMed     Text format     Abstract available

  44. NARAN NH, Haagensen M, Crowther NJ
    Steatosis in South African women: How much and why?
    PLoS One. 2018;13:e0191388.
    PubMed     Text format     Abstract available

  45. FERRIGNO A, Di Pasqua LG, Berardo C, Siciliano V, et al
    The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
    PLoS One. 2018;13:e0191430.
    PubMed     Text format     Abstract available

  46. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0191026.
    PubMed     Text format     Abstract available


    Transplant Proc

  47. BAEK SD, Jang M, Kim W, Yu H, et al
    Benefits of Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation in Patients With Renal Dysfunction.
    Transplant Proc. 2017;49:1344-1350.
    PubMed     Text format     Abstract available

  48. YANG L, Xin EY, Liao B, Lai LJ, et al
    Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
    Transplant Proc. 2017;49:1357-1363.
    PubMed     Text format     Abstract available

  49. STANKIEWICZ R, Kornasiewicz O, Grat M, Lewandowski Z, et al
    Is Elective Status a Predictor of Poor Survival in Liver Retransplantation?
    Transplant Proc. 2017;49:1364-1368.
    PubMed     Text format     Abstract available

  50. KRESPI MR, Tankurt A, Acarli K, Kanmaz T, et al
    Beliefs of Living Donors About Recipients' End-Stage Liver Failure and Surgery for Organ Donation.
    Transplant Proc. 2017;49:1369-1375.
    PubMed     Text format     Abstract available

  51. ELKHOLY S, Mogawer S, Hosny A, El-Shazli M, et al
    Predictors of Mortality in Living Donor Liver Transplantation.
    Transplant Proc. 2017;49:1376-1382.
    PubMed     Text format     Abstract available


    Transplantation

  52. GIARD JM, Mehta N, Dodge JL, Roberts JP, et al
    Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2018 Jan 17. doi: 10.1097/TP.0000000000002094.
    PubMed     Text format     Abstract available

  53. KIM JM, Kwon CHD, Joh JW, Han S, et al
    ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Transplantation. 2018 Feb 28. doi: 10.1097/TP.0000000000002154.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: